Home › Funds › LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA › MRK

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA position in MRK

MERCK & CO · Health Care

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA reported holding 329,146 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$47.8M, representing 0.44% of its reported portfolio and ranking #49 among its reported holdings. LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)329.15K sh
Reported value held$47.83M
Portfolio Weight0.44%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's MRK position evolved

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA first disclosed a stake in MRK in Q3 2023 at 430,529 shares (US$44.3M). The position peaked in Q1 2024 at 421,819 shares, worth US$53.5M. Across 13 filings, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA increased the stake 0 time(s), trimmed it 12 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 329,146 shares valued at US$47.8M — a reduction of -3,589 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 430.53K $44.28M New
Q4 2023 427.09K $51.58M Reduce
Q1 2024 421.82K $53.55M Reduce
Q2 2024 418.98K $52.56M Reduce
Q3 2024 415.76K $44.02M Reduce
Q4 2024 406.55K $39.82M Reduce
Q1 2025 393.67K $31.00M Reduce
Q2 2025 379.06K $30.01M Reduce
Q3 2025 363.80K $31.72M Reduce
Q4 2025 345.01K $37.23M Reduce
Q1 2026 337.03K $40.92M Reduce
Q2 2026 332.74K $42.76M Reduce
Q3 2026 329.15K $47.83M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA held MRK?

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's current position in MRK?

As of Q3 2026, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds 329.15K shares of MRK (MERCK & CO), valued at $47.83M, representing 0.44% of its reported portfolio and ranking #49.

Has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA been buying or selling MRK?

In the latest 13F filing (Q3 2026), LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA reduced its position in MRK. The position peaked in Q1 2024 at 421.82K shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.